- Home
- RVMD vs TKO Comparison
RVMD vs TKO Comparison
Compare RVMD & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVMD | TKO |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 14.5B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | RVMD | TKO |
|---|---|---|
| Price | $103.19 | $224.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 17 |
| Target Price | $114.63 | ★ $224.87 |
| AVG Volume (30 Days) | ★ 1.7M | 752.0K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | N/A | ★ 11200.00 |
| EPS | N/A | ★ 2.26 |
| Revenue | N/A | ★ $4,735,151,000.00 |
| Revenue This Year | N/A | $28.44 |
| Revenue Next Year | $552.08 | N/A |
| P/E Ratio | ★ N/A | $99.14 |
| Revenue Growth | N/A | ★ 68.85 |
| 52 Week Low | $29.17 | $133.07 |
| 52 Week High | $124.49 | $226.94 |
Technical Indicators
Market Signals| Indicator | RVMD | TKO |
|---|---|---|
| Relative Strength Index (RSI) | 55.58 | 62.35 |
| Support Level | $92.76 | $194.71 |
| Resistance Level | $124.49 | N/A |
| Average True Range (ATR) | 3.62 | 7.93 |
| MACD | 0.23 | 1.35 |
| Stochastic Oscillator | 67.28 | 85.94 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About TKO TKO Group Holdings Inc.
TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.